APLE vs BMRN · P/E 21, rev $1.43B vs P/E 40, rev $2.85B
Apple Hospitality REIT Inc (APLE) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.
Apple Hospitality REIT Inc (APLE) is a reit - hotel & motel company listed on US.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported APLE revenue for 2024-12-31 was $1.43B. Net income was $214.1M. Revenue was up 6.5% from 2023-12-31 to 2024-12-31. APLE currently screens at market cap $3.69B and trailing P/E 21.4.
Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
APLE currently screens at market cap $3.69B and trailing P/E 21.4. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Not investment advice. Open the APLE and BMRN stock pages for the full models.
Not investment advice.